Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Decreasing Risk of Recurrence by TAF in HCC Patients After Curative Treatment With Low HBV Viral Load

NCT04290936 is registered in ClinicalTrials.gov with Taipei Veterans General Hospital, Taiwan as lead sponsor.

NCT NCT04290936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04290936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Decreasing Risk of Recurrence by TAF in HCC Patients After Curative Treatment With Low HBV Viral Load
Lead sponsor
Taipei Veterans General Hospital, Taiwan
Phase
Phase 4
Overall status
Unknown status
Start date
October 16, 2020
Completion date
December 31, 2024
Enrollment
402 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hcc patients after curative treatment with low hbv viral load